Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students
This study evaluates the efficacy of a group-based Acceptance and Commitment Therapy (ACT) protocol compared to a non-directive group therapy used as an active control condition in university students presenting moderate to moderate/high levels of emotional symptomatology. Emotional difficulties such as depressive and
| Condition(s) | Depression, Anxiety |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study evaluates the efficacy of a group-based Acceptance and Commitment Therapy (ACT) protocol compared to a non-directive group therapy used as an active control condition in university students presenting moderate to moderate/high levels of emotional symptomatology. Emotional difficulties such as depressive and anxiety symptoms are highly prevalent among university students and may negatively affect academic performance, well-being, and long-term functioning. Acceptance and Commitment Therapy (ACT) is an evidence-based psychological intervention that aims to improve mental health by increasing psychological flexibility, the ability to act in accordance with personal values while remaining open to difficult internal experiences. Participants will be randomly assigned to either (1) a |
| Who can participate | Inclusion Criteria: * University students aged 18 to 28 years. * Score ≥8 on the PHQ-9. * Score ≥8 on the GAD-7. * Willingness to participate in a longitudinal study including pre-, post-, and follow-up assessments. * Willingness to complete daily and weekly ecological momentary assessments (EMA). * Provision of written informed consent. Exclusion Criteria: * Suicide risk based on clinical indicators derived from PHQ-9 assessment. * Self-reported history of psychotic disorders. * Self-reported problematic substance use. * Failure to provide informed consent. |
| Ages | 18 Years to 28 Years |
| Sex | All |
| Lead sponsor | Mónica Larrosa Signorelli |
| Locations | Montevideo, Montevideo Department, Uruguay |
| Start date | 2026-03-20 |
| NCT ID | NCT07506148 |
| Official listing | https://clinicaltrials.gov/study/NCT07506148 |